(19)
(11) EP 2 485 743 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
09.10.2013 Bulletin 2013/41

(45) Mention of the grant of the patent:
28.08.2013 Bulletin 2013/35

(21) Application number: 10757610.0

(22) Date of filing: 28.09.2010
(51) International Patent Classification (IPC): 
A61K 35/74(2006.01)
 A61P 9/00(2006.01)
(86) International application number:
PCT/EP2010/064304
(87) International publication number:
WO 2011/042333 (14.04.2011 Gazette 2011/15)

(54)

LACTOBACILLUS PLANTARUM STRAINS AS HYPOCHOLESTEROLEMIC AGENTS.

LACTOBACILLUS PLANTARUM-STÄMME ALS HYPOCHOLESTERINÄMISCHE MITTEL.

SOUCHES DE LACTOBACILLUS PLANTARUM CONVENANT COMME HYPOCHOLESTÉROLÉMIANTS.

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated Extension States:
BA ME RS

(30) Priority: 09.10.2009 EP 09172613
30.11.2009 US 265095 P

(43) Date of publication of application:
15.08.2012 Bulletin 2012/33

(73) Proprietor: AB-Biotics S.A.
Barcelona (ES)

(72) Inventor:
  • CUÑÉ CASTELLANA, Jordi
    E-08193 Bellaterra (ES)

(74) Representative: ZBM Patents 
Zea, Barlocci & Markvardsen Plaza Catalunya, 1
08002 Barcelona
08002 Barcelona (ES)


(56) References cited: : 
WO-A1-2006/025643
 WO-A1-2009/068474
   
  • BUKOWSKA H ET AL: "LETTERS TO THE EDITORS//DECREASE IN FIBRINOGEN AND LDL-CHOLESTEROL LEVELS UPON SUPPLEMENTATION OF DIET WITH LACTOBACILLUS PLANTARUM IN SUBJECTS WITH MODERATELY ELEVATED CHOLESTEROL", ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, IE, vol. 137, 1 January 1998 (1998-01-01), page 437/438, XP002909965, ISSN: 0021-9150 cited in the application
  • GOLDSTEIN M R ET AL: "Point: Statins, plant sterol absorption, and increased coronary risk", JOURNAL OF CLINICAL LIPIDOLOGY, ELSEVIER, NEW YORK, NY, US, vol. 2, no. 4, 1 August 2008 (2008-08-01), pages 304-305, XP023613118, ISSN: 1933-2874, DOI: DOI:10.1016/J.JACL.2008.06.005 [retrieved on 2008-06-13] cited in the application
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).